David Hendlin

2.8k total citations · 2 hit papers
59 papers, 2.1k citations indexed

About

David Hendlin is a scholar working on Molecular Biology, Pharmacology and Organic Chemistry. According to data from OpenAlex, David Hendlin has authored 59 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 23 papers in Pharmacology and 10 papers in Organic Chemistry. Recurrent topics in David Hendlin's work include Antibiotics Pharmacokinetics and Efficacy (11 papers), Antibiotic Resistance in Bacteria (10 papers) and Microbial Natural Products and Biosynthesis (7 papers). David Hendlin is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (11 papers), Antibiotic Resistance in Bacteria (10 papers) and Microbial Natural Products and Biosynthesis (7 papers). David Hendlin collaborates with scholars based in United States and Germany. David Hendlin's co-authors include E. O. Stapley, H. B. Woodruff, H. Wallick, A. Kathrine Miller, M. Jackson, Sebastian Hernandez, S. Mochales, Thomas W. Miller, Frederick M. Kahan and J.M. Mata and has published in prestigious journals such as Nature, Science and Journal of Biological Chemistry.

In The Last Decade

David Hendlin

59 papers receiving 1.8k citations

Hit Papers

Phosphonomycin, a New Antibiotic Produced by Strains of S... 1969 2026 1988 2007 1969 1979 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Hendlin United States 21 936 880 637 522 278 59 2.1k
Jerome Birnbaum United States 17 839 0.9× 1.0k 1.2× 569 0.9× 354 0.7× 221 0.8× 35 2.4k
Jean S. Kahan United States 6 482 0.5× 776 0.9× 682 1.1× 408 0.8× 300 1.1× 6 1.6k
H. Wallick United States 11 611 0.7× 553 0.6× 315 0.5× 267 0.5× 239 0.9× 16 1.6k
Christopher Reading United States 13 640 0.7× 875 1.0× 582 0.9× 286 0.5× 207 0.7× 21 1.6k
M. Jackson United States 10 460 0.5× 515 0.6× 365 0.6× 389 0.7× 235 0.8× 14 1.2k
A. Kathrine Miller United States 11 414 0.4× 513 0.6× 419 0.7× 368 0.7× 224 0.8× 25 1.2k
Frederick M. Kahan United States 16 1.1k 1.2× 1.5k 1.8× 1.4k 2.2× 791 1.5× 698 2.5× 17 3.6k
S. Mochales United States 9 486 0.5× 563 0.6× 378 0.6× 351 0.7× 203 0.7× 10 1.3k
Phaik‐Eng Sum United States 19 534 0.6× 496 0.6× 682 1.1× 290 0.6× 161 0.6× 32 1.5k
Ving J. Lee United States 21 1.0k 1.1× 687 0.8× 1.4k 2.2× 518 1.0× 365 1.3× 45 2.2k

Countries citing papers authored by David Hendlin

Since Specialization
Citations

This map shows the geographic impact of David Hendlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Hendlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Hendlin more than expected).

Fields of papers citing papers by David Hendlin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Hendlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Hendlin. The network helps show where David Hendlin may publish in the future.

Co-authorship network of co-authors of David Hendlin

This figure shows the co-authorship network connecting the top 25 collaborators of David Hendlin. A scholar is included among the top collaborators of David Hendlin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Hendlin. David Hendlin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stapley, E. O., Jerome Birnbaum, A. Kathrine Miller, et al.. (1979). Cefoxitin and Cephamycins: Microbiological Studies. Clinical Infectious Diseases. 1(1). 73–87. 36 indexed citations
2.
Birnbaum, Jerome, E. O. Stapley, A. Kathrine Miller, et al.. (1979). Development of the semisynthetic cephamycin, cefoxitin, as a clinical candidate. Infection. 7(S1). S13–S20. 4 indexed citations
3.
Kahan, Jean S., Frederick M. Kahan, Robert T. Goegelman, et al.. (1979). Thienamycin, a new .BETA.-lactam antibiotic. I. Discovery, taxonomy, isolation and physical properties.. The Journal of Antibiotics. 32(1). 1–12. 388 indexed citations breakdown →
4.
Woodruff, H. B., J.M. Mata, Sebastían Hernández, et al.. (1977). Fosfomycin: Laboratory Studies. Chemotherapy. 23(1). 1–22. 47 indexed citations
5.
Miller, A. Kathrine, et al.. (1972). Cephamycins, a New Family of β-Lactam Antibiotics. III. In Vitro Studies. Antimicrobial Agents and Chemotherapy. 2(4). 281–286. 11 indexed citations
6.
Stapley, E. O., David Hendlin, M. Jackson, et al.. (1971). AZIRINOMYCIN. I. The Journal of Antibiotics. 24(1). 42–47. 48 indexed citations
7.
Kropp, H, et al.. (1969). Phosphonomycin. V. Evaluation in mice.. PubMed. 9. 310–5. 9 indexed citations
8.
Hendlin, David, E. O. Stapley, M. Jackson, et al.. (1969). Phosphonomycin, a New Antibiotic Produced by Strains of Streptomyces. Science. 166(3901). 122–123. 473 indexed citations breakdown →
9.
Demain, A. L., et al.. (1966). Production of Guanosine-5′-Monophosphate and Inosine-5′-Monophosphate by Fermentation. Applied Microbiology. 14(5). 821–825. 19 indexed citations
10.
Demain, A. L., Richard W. Burg, & David Hendlin. (1965). Excretion and Degradation of Ribonucleic Acid by Bacillus subtilis. Journal of Bacteriology. 89(3). 640–646. 36 indexed citations
11.
Kaczka, Edward A., Eugene L. Dulaney, Malcolm Smith, et al.. (1963). Discovery of inhibitory activity of tenuazonic acid for growth of human adenocarcinoma-1. Biochemical and Biophysical Research Communications. 14(1). 54–57. 37 indexed citations
12.
Claridge, C. A. & David Hendlin. (1962). OXIDATION OF GLYCEROL BYSTREPTOCOCCUS FAECALIS. Journal of Bacteriology. 84(6). 1181–1186. 4 indexed citations
13.
Gray, Reed A. & David Hendlin. (1962). Growth Inhibition & Bleaching in Higher Plants & Euglena by O-Methylthreonine; Reversal by Isoleucine. PLANT PHYSIOLOGY. 37(2). 223–227. 5 indexed citations
14.
Hendlin, David & Thomas M. Cook. (1960). The Activity of Coenzyme Q10 and Its Analogues in the Succinoxidase System of Electron Transport Particles. Journal of Biological Chemistry. 235(4). 1187–1191. 13 indexed citations
15.
Demain, A. L., et al.. (1959). ROLE OF FATTY ACIDS IN THE GROWTH STIMULATION OF SARCINA SPECIES BY VITAMIN-FREE CASEIN DIGESTS. Journal of Bacteriology. 78(6). 839–843. 12 indexed citations
16.
Hendlin, David, et al.. (1954). RELATIONSHIP BETWEEN VITAMIN B 12 OXIDATION PRODUCT AND SODIUM CHLORIDE TOXICITY FOR LACTOBACILLI. Journal of Bacteriology. 67(1). 38–40. 5 indexed citations
17.
Hendlin, David, et al.. (1953). INVESTIGATIONS ON THE BIOSYNTHESIS OF CITROVORUM FACTOR BY LACTIC ACID BACTERIA. Journal of Bacteriology. 65(4). 466–471. 20 indexed citations
18.
Hendlin, David. (1953). DISCUSSION OF THE PAPERS ON VITAMIN B12. Annals of the New York Academy of Sciences. 56(5). 870–872. 3 indexed citations
19.
Hendlin, David, et al.. (1951). THE USE OF POTASSIUM CYANIDE IN THE LACTOBACILLUS LEICHMANNII ASSAY FOR VITAMIN B 12. Journal of Bacteriology. 62(1). 15–17. 9 indexed citations
20.
Hendlin, David, et al.. (1951). COMPARATIVE MICROBIOLOGICAL STUDIES WITH VITAMINS B12 AND B12a. Journal of Biological Chemistry. 188(2). 603–610. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026